Becton, Dickinson and Company (BDX) — Stock Score Summary

Becton, Dickinson and Company (BDX) has a MoatMap StockRank of 85/100 based on Quality (51/100), Value (62/100), and Momentum (58/100) factor scores. The current signal is STRONG BUY. Becton, Dickinson and Company is a premier medical technology giant with an un-copyable moat in clinical consumables and diagnostic systems. As healthcare systems globally prioritize supply chain localization and regional medical inventory resilience, BDX's highly diversified, localized manufacturing footprint makes it an indispensable partner, offering highly visible, recurring cash flows.

Becton, Dickinson and Company (BD) is a global medical technology company developing, manufacturing, and selling medical devices, instrument systems, and reagents. BD is a market leader in critical healthcare segments like medication management, infection prevention, and diagnostic systems, supported by a vast intellectual property portfolio and global distribution. It is a highly diversified and essential supplier to the global healthcare industry, known for its broad product portfolio and significant installed base.

Key Financial Metrics

Price$144.43
Market Cap$40.9B
P/E (TTM)25.79
P/E (Forward)10.99
Price/Book1.69
Return on Equity6.7%
Return on Invested Capital5.3%
Debt/Equity71.60
Gross Margin47.1%
Operating Margin14.7%
Revenue Growth5.2%
Dividend Yield2.8%
Free Cash Flow$4.5B

Becton, Dickinson and Company operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Becton, Dickinson and Company’s (BDX) StockRank?
MoatMap’s StockRank for Becton, Dickinson and Company (BDX) is 85/100, with a Strong Buy signal. It is a composite of Quality (51), Value (62), and Momentum (58) factor ranks across MoatMap’s 19,000+ stock universe.
Does Becton, Dickinson and Company have an economic moat?
Becton, Dickinson and Company (BDX) has a Quality factor score of 51/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Becton, Dickinson and Company a buy, hold, or sell?
MoatMap’s current signal for Becton, Dickinson and Company (BDX) is Strong Buy, based on a StockRank of 85/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Becton, Dickinson and Company in?
Becton, Dickinson and Company (BDX) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (United States).
Browse all ranked stocksBDX deep dive reportAI ChampionsHow we score stocksSense-check another stock